Filoviruses (viruses in the genus Ebolavirus and Marburgvirus in the family Filoviridae) 25 cause severe haemorrhagic fever in humans and nonhuman primates. Rapid, highly sensitive, 26 and reliable filovirus-specific assays are required for diagnostics and outbreak control. 27
Introduction 48
Filoviruses are among the most lethal human pathogens recognized to date with case 49 fatality rates up to 90%, depending on the virus species and strain (Pittalis et The lack of therapeutics and vaccines for filovirus infections and the fact that other 63 pathogens cause clinical symptoms comparable to those of Ebola and Marburg haemorrhagic 64 fever highlights the need for rapid, sensitive, reliable and virus-specific diagnostic tests to 65 control the spread of these viruses (Qiu et al., 2011; Sanchez et al., 2007) . Rapid antigen-66 detection tests with filovirus-specific monoclonal antibodies (mAb) are likely one of the best 67 ways for early diagnosis of filovirus infections in the field setting. NP may be the ideal target 68 antigen because of its abundance in filovirus particles and its strong antigenicity (Niikura et 
Specificity and cross-reactivity of NP-specific mAbs 172
In the first screening process, we obtained 126 hybridomas producing mAbs reactive 173 to the recombinant EBOV NP. None of them showed cross-reactivity to MARV NP. These 174 mAbs were further assessed by ELISA for their cross-reactivity with the recombinant NPs of 175 the other known Ebolavirus species (SUDV, TAFV, BDBV and RESTV). We found several 176 different profiles for the cross-reactivities of these mAbs. Representative clones for each 177 obtained cross-reactivity profile showing the highest OD 450 values were selected and further 178 cloned by limiting dilution. We then established 10 clones of NP-specific mAbs (ZNP31-1-8, 179
ZNP41-2-4, ZNP74-7, ZNP24-4-2, ZNP106-9, ZNP108-2-5, ZNP105-7, ZNP98-7, ZNP35-180 16-3-5 and ZNP62-7) which were divided into 7 groups based on their cross-reactivity 181 profiles in ELISA (Table 1) . Four mAbs (ZNP31-1-8, ZNP41-2-4, ZNP74-7 and ZNP24-4-2) 182 reacted with all known viruses of Ebolavirus species, with one (ZNP24-4-2) having relatively 183 weak reactivity with SUDV. Four mAbs (ZNP106-9, ZNP108-2-5, ZNP105-7 and ZNP98-7) 184 bound to NPs of some viruses in addition to EBOV, and 2 mAbs (ZNP35-16-3-5 and ZNP62-185 7) reacted only to EBOV. Importantly, these different reactivity profiles enabled us to 186 distinguish the known Ebolavirus species by using combinations of these MAbs: EBOV was 187 recognised by all the mAbs, SUDV by ZNP31-1-8, ZNP41-2-4, ZNP74-7, ZNP24-4-2 and 188 ZNP106-9; TAFV by ZNP31-1-8, ZNP41-2-4, ZNP74-7, ZNP24-4-2, ZNP106-9 and 189 ZNP108-2-5; BDBV by ZNP31-1-8, ZNP41-2-4, ZNP74-7, ZNP24-4-2, ZNP106-9, 190 ZNP108-2-5, ZNP105-7 and ZNP98-7; and RESTV by ZNP31-1-8, ZNP41-2-4, ZNP74-7, 191 ZNP24-4-2 and ZNP105-7. The reactivities of these NP-specific mAbs were further tested by 192
Western blotting using lysates of actual filovirus particles grown in Vero E6 cells (Fig. 1) . ZNP41-2-4, ZNP74-7, ZNP24-4-2, ZNP106-9, ZNP98-7, ZNP35-16-3-5 and ZNP62-7) 207 bound to at least one peptide, whereas 2 (ZNP108-2-5 and ZNP105-7) had no positive 208 reaction (Fig. 2) . The amino acid sequences recognised by these 8 mAbs are summarized in 209 Table 2 
Reactivity of rabbit antisera produced by immunisation with synthetic peptides. 220
We then sought to determine epitopes distinctive among the NPs of each Ebolavirus 221 and Marburgvirus species. Based on a program used to predict B-cell epitopes, we selected 222 region around aa positions 630-650 from viruses representing each filovirus species (Fig. 3)  223 (EBOV, SUDV, TAFV, BDBV, RESTV and MARV), and generated rabbit antisera to the 224 respective synthetic peptides as described in Materials and Methods. The reactivity of each 225 antiserum (FS0169, FS0191, FS0046, FS0048, FS0170 and FS0610 ) was analysed by ELISA 226 (Table 3 ). According to the high sequence variation in this region among these viruses, the 227 antisera reacted specifically with the homologous NPs, although FS0046 and FS0048 228 (antisera to TAFV and BDBV, respectively), showed limited cross-reactivity to RESTV NP. 229
The virus specificity was further confirmed using filovirus lysates in Western blotting (Fig. 4) . 230
Notably, all the virus strains tested within the genus Marburgvirus (including RAVV) were 231 recognized by antiserum FS0610. These results indicated that the region around aa 630-650 232 in filovirus NP served as a filovirus species-specific epitope. 233 234 235
Discussion 236
Using mouse mAbs and synthetic peptide-based scanning, we determined 2 highly 237 conserved antigenic regions (aa 421-440 and aa 601-620) serving as linear epitopes in the 238 filovirus NP (Fig. 3) . In addition, a stretch of 10 amino acids at aa 421-430 (YDDDDDIPFP) 239 was found to be important for 3 mAbs (ZNP31-1-8, ZNP41-2-4 and ZNP74-7), which 240 strongly recognized all known Ebolavirus species. This finding is consistent with a previous 241 study demonstrating that mAbs reactive to EBOV, RESTV and SUDV recognised the 242 sequence at aa 424-430 (Niikura et al., 2003) . In this specific region, the amino acid sequence 243 IPFP is completely conserved among all analysed viruses in the Ebolavirus genus, suggesting 244 that these aa residues are crucial for conformation of this common epitope. 245 ZNP24-4-2 was highly cross-reactive to all known viruses of the genus Ebolavirus, 246 with weaker reactivity to SUDV (Table 1 and Fig. 1 ). This mAb reacted with two different 247 peptides corresponding to aa 521-540 and aa 601-620 (Fig. 2) . These two peptide sequences 248 may be parts of a conformational epitope. However, there is no conserved sequence in the 249 region at aa 521-540 among all the analysed viruses, whereas the sequence at aa 601-620 250 shows some conservation. Although SUDV was only weakly recognised by this mAb, this 251 conserved region might be required for recognition as a conserved epitope. 252 ZNP106-9 and ZNP108-2-5 were strongly reactive to EBOV, TAFV and BDBV, but 253 only weakly reactive or nonreactive to SUDV and RESTV, respectively. This reactivity 254 pattern is consistent with the phylogenetic relationship among the viruses (Towner et al., 255 2008). Only ZNP106-9 reacted with the peptide sequence D 451 TTIPDVVVD 460 , 256 demonstrating that ZNP108-2-5 recognises a different epitope. The amino acid sequence 257 alignment of this region suggests that D 456 in EBOV, TAFV and BDBV is critical for the 258 ZNP106-9 specificity to these viruses, since SUDV and RESTV have G or N at this aa 259 position, respectively (Fig. 3) . 260 ZNP35-16-3-5 and ZNP62-7 recognised EBOV only, and bound to aa 611-630 and aa 261 491-510, respectively. According to the sequence variation among the analyzed viruses, these 262 aa likely form EBOV-specific epitopes. It can be speculated that the same region of NP of the 263 other viruses in the Ebolaviruse genus forms species-specific epitopes. In addition to these 264 two regions, the success of the production of antisera to the synthetic peptides with the 265 predicted sequences around aa 630-650 provided further information on the filovirus species-266 specific epitopes. The antigenic region of EBOV NP was previously shown to be located in 267 the C-terminal half of the protein (Saijo et al., 2001 ). The N-terminal aa 1-451 of the EBOV 268 NP assemble into a condensed helix, which forms the inner structure of the viral nucleocapsid 269 (Bharat et al., 2012) . The amino acid residues in this region are highly conserved among the 270 known viruses in the genus Ebolavirus. It is likely that this region forms functionally 271 important structures inside the NP molecule, and as a result, has limited antigenic properties. 272 This is consistent with our results in which most antigenic regions were found in the highly 273 variable C-terminal region starting at aa 451 (Fig. 3) . The only epitope found on the 274 condensed helix structure was the one recognised by ZNP31-1-8, ZNP41-2-4 and ZNP74-7, 275 mAbs cross-reactive to all known Ebolavirus species. 276
In this study, we established a panel of NP-specific mAbs divided into 7 groups based 277 on their cross-reactivity profiles to all known viruses of the genus Ebolavirus. 2.5µg/ml. ++, OD ≥ 1.0, +, 0.5 < OD < 1; -, OD ≤ 0.5. 5 1:2,000. ++, OD ≥ 1.0; +, 0.5 < OD < 1; -, OD ≤ 0.5.
